In search of negative allosteric modulators of biological targets
Drug Discovery Today, 2009The value of using negative allosteric modulators of protein function in therapeutic treatment of human diseases is becoming more apparent. Many current screening paradigms, however, are not consciously designed to discover negative allosteric modulators, and those that are serendipitously discovered can be easily overlooked during the hit-picking ...
openaire +2 more sources
PKCε acts as negative allosteric modulator of EGF receptor signalling
Cellular Signalling, 2011Protein kinase C ε (PKCε) is a transforming oncogene and plays a pivotal role in numerous cellular processes including proliferation, invasion and differentiation. Recently, we described a function of PKCε as a scaffold protein linking PLCγ1 to the EGFR module.
Simona, Weisheit +4 more
openaire +2 more sources
Extracellular binding sites of positive and negative allosteric P2X4 receptor modulators
Life Sciences, 2022P2X receptors are ATP-gated ion channels which play a role in many pathophysiological conditions. They are considered as novel drug targets, particularly in the fields of pain, (neuro) inflammation, and cancer. Due to difficulties in developing drug-like orthosteric ligands that bind to the highly polar ATP binding site, the design of positive and ...
Stephanie Weinhausen +7 more
openaire +2 more sources
The discovery of novel calcium sensing receptor negative allosteric modulators
Bioorganic & Medicinal Chemistry Letters, 2009The design and profile of a series of zwitterionic calcium sensing receptor negative allosteric modulators is described. Evaluation of key analogues using a rat model demonstrate a robust response, significantly improved potency over ronacaleret and have the potential as an oral, anabolic treatment for osteoporosis.
Gayatri, Balan +23 more
openaire +2 more sources
A negative allosteric modulator modulates GABAB-receptor signalling through GB2 subunits
Biochemical Journal, 2016An γ-aminobutyric acid type B (GABAB)-receptor mediates slow and prolonged synaptic inhibition in the central nervous system, which represents an interesting target for the treatment of various diseases and disorders of the central nervous system.
Bing, Sun +6 more
openaire +2 more sources
Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
Journal of Neurogenetics, 2011There is growing evidence suggesting that antagonists of group II metabotropic glutamate receptors (mGluR2/3) exhibit antidepressant-like properties in several preclinical models of depression. However, all those studies have been performed using competitive group II non-selective orthosteric antagonists.
Campo, Brice +13 more
openaire +3 more sources
Nanobodies as negative allosteric modulators for human calcium sensing receptor
Biochemical and Biophysical Research CommunicationsHuman calcium sensing receptor (CaSR) senses calcium ion concentrations in vivo and is an important class of drug targets. Mutations in the receptor can lead to disorders of calcium homeostasis, including hypercalcemia and hypocalcemia. Here, 127 CaSR-targeted nanobodies were generated from camels, and four nanobodies with inhibitory function were ...
Qianqian Cui +16 more
openaire +2 more sources
COR758, a negative allosteric modulator of GABA receptors
Neuropharmacology, 2021Miriam Melis +2 more
exaly
Understanding the Allosteric Modulation of PTH1R by a Negative Allosteric Modulator
Cells, 2023Lili Xi, Mengrong Li, Yiqiong Bao
exaly
Identification of a β-arrestin-biased negative allosteric modulator for the β2-adrenergic receptor
Proceedings of the National Academy of Sciences of the United States of America, 2023Joseph M Salvino +2 more
exaly

